Lanean...
Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity
BACKGROUND: Human recombinant erythropoietin (rHuEpo) that is used for the treatment of the chemotherapy-induced anaemia in cancer patients was shown to cause detrimental effects on the course of disease due to increased adverse events inflicting patient’s survival, potentially related to rHuEpo-ind...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Versita, Warsaw
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472952/ https://ncbi.nlm.nih.gov/pubmed/23077460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10019-012-0037-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|